ArticleClinical ophthalmology (Auckland, N.Z.)2018

Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model.

Edward J Meier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.